Rodney Sinclair

Tildrakizumab versus placebo or etanercept for chronic plaque psoriasis (reSURFACE 1 and reSURFACE 2): results from two randomised controlled, phase 3 trials

Kristian Reich, Kim Papp, Andrew Blauvelt et al. · The Lancet · 2017 · 556 citations

Medicine, Dermatology, Pharmacotherapy +10

Efficacy and safety of abrocitinib in adults and adolescents with moderate-to-severe atopic dermatitis (JADE MONO-1): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

Eric L. Simpson, Rodney Sinclair, Seth Forman et al. · The Lancet · 2020 · 491 citations · Full text

Medicine, Dermatology, Immunology +14

Development and validation of the International Hidradenitis Suppurativa Severity Score System ( <scp>IHS</scp> 4), a novel dynamic scoring system to assess <scp>HS</scp> severity

Christos C. Zouboulis, Thrasyvoulos Tzellos, Gregor B. E. Jemec et al. · British Journal of Dermatology · 2017 · 454 citations · Full text

Medicine, Dermatology, Clinical Epidemiology +13

Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis

Thomas Bieber, Eric L. Simpson, Jonathan I. Silverberg et al. · New England Journal of Medicine · 2021 · 453 citations · Full text

Medicine, Dermatology, Pharmacology +15

Comparative Analysis of Paracrine Factor Expression in Human Adult Mesenchymal Stem Cells Derived from Bone Marrow, Adipose, and Dermal Tissue

Sarah Hsiao, Azar Asgari, Zerina Lokmic‐Tomkins et al. · Stem Cells and Development · 2011 · 418 citations

Life Sciences, Biomedical Engineering, Cell Biology +15